by James Damschroder | May 12, 2020 | Portfolio ThinkTank |
I track a list of 3 COVID 19 Stock ideas. Harmed is an equally weighted basket of 33 stocks that would stand to get their butt kicked by COVID19 and the resulting shutdown. Beneficiaries is an equally weighted basket of 33 stocks that one could imagine would benefit;...
by James Damschroder | May 1, 2020 | Portfolio ThinkTank |
Narrative Diversification – What is it and why does it matter? I want to call to attention a type of diversification that I think is especially relevant now and typically one that evades measurement. Narrative diversification. I’ve come across this type of...
by James Damschroder | March 18, 2020 | Portfolio ThinkTank |
Cash + Quality + Cap = Comebackability A great many stocks are excellent investments right now. With the Coronavirus, I keep finding myself saying that “this too shall pass.” It will. Sooner or later. And when it does – you need to be ready. As there have...
by James Damschroder | March 4, 2020 | Portfolio ThinkTank |
I’ve been thinking a lot about this lately. The recent impact of the coronavirus fears on the stock market, like any other fast-moving or high-volatility event arouses my trader’s instincts. Are those trader’s instincts compatible with fiduciary, long-term...
